Literature DB >> 19721787

Staphylococcus pseudintermedius necrotizing fasciitis in a dog.

J Scott Weese1, Roberta Poma, Fiona James, Gilbert Buenviaje, Robert Foster, Durda Slavic.   

Abstract

Staphylococcus pseudintermedius was implicated as the cause of rapidly progressive and fatal necrotizing fasciitis in a dog. The isolate was methicillin-susceptible and did not contain genes encoding the Panton-Valentine leukocidin. While Streptococcus canis is typically considered to be the main cause of necrotizing fasciitis in dogs, staphylococci should also be considered.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19721787      PMCID： PMC2684055     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


  17 in total

1.  Staphylococcus intermedius cellulitis and toxic shock in a dog.

Authors:  C Girard; R Higgins
Journal:  Can Vet J       Date:  1999-07       Impact factor: 1.008

2.  Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?

Authors:  Jovanka M Voyich; Michael Otto; Barun Mathema; Kevin R Braughton; Adeline R Whitney; Diane Welty; R Daniel Long; David W Dorward; Donald J Gardner; Gérard Lina; Barry N Kreiswirth; Frank R DeLeo
Journal:  J Infect Dis       Date:  2006-11-02       Impact factor: 5.226

Review 3.  Necrotizing soft-tissue infection: diagnosis and management.

Authors:  Daniel A Anaya; E Patchen Dellinger
Journal:  Clin Infect Dis       Date:  2007-01-22       Impact factor: 9.079

4.  Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles.

Authors:  Loren G Miller; Francoise Perdreau-Remington; Gunter Rieg; Sheherbano Mehdi; Josh Perlroth; Arnold S Bayer; Angela W Tang; Tieu O Phung; Brad Spellberg
Journal:  N Engl J Med       Date:  2005-04-07       Impact factor: 91.245

5.  Update on canine streptococcal toxic shock syndrome and necrotizing fasciitis.

Authors:  J F Prescott; C W Miller; K A Mathews; J A Yager; L DeWinter
Journal:  Can Vet J       Date:  1997-04       Impact factor: 1.008

6.  Streptococcal toxic shock syndrome in dogs.

Authors:  C W Miller; J F Prescott; K A Mathews; S D Betschel; J A Yager; V Guru; L DeWinter; D E Low
Journal:  J Am Vet Med Assoc       Date:  1996-10-15       Impact factor: 1.936

7.  Staphylococcus pseudintermedius sp. nov., a coagulase-positive species from animals.

Authors:  Luc A Devriese; Marc Vancanneyt; Margo Baele; Mario Vaneechoutte; Evelyne De Graef; Cindy Snauwaert; Ilse Cleenwerck; Peter Dawyndt; Jean Swings; Annemie Decostere; Freddy Haesebrouck
Journal:  Int J Syst Evol Microbiol       Date:  2005-07       Impact factor: 2.747

8.  First case of Staphylococcus pseudintermedius infection in a human.

Authors:  Lieve Van Hoovels; Anne Vankeerberghen; An Boel; Kristien Van Vaerenbergh; Hans De Beenhouwer
Journal:  J Clin Microbiol       Date:  2006-10-18       Impact factor: 5.948

9.  Screening of Staphylococcus aureus, Staphylococcus intermedius, and Staphylococcus schleiferi isolates obtained from small companion animals for antimicrobial resistance: a retrospective review of 749 isolates (2003-04).

Authors:  Daniel O Morris; Kathryn A Rook; Frances S Shofer; Shelley C Rankin
Journal:  Vet Dermatol       Date:  2006-10       Impact factor: 1.589

10.  Panton valentine leukocidin (PVL) toxin positive MRSA strains isolated from companion animals.

Authors:  Shelley Rankin; Scott Roberts; Kathleen O'Shea; Donna Maloney; Marianne Lorenzo; Charles E Benson
Journal:  Vet Microbiol       Date:  2005-04-21       Impact factor: 3.293
View more
  6 in total

1.  Necrotizing fasciitis caused by methicillin-resistant Staphylococcus pseudintermedius at a previously irradiated site in a dog.

Authors:  Monique N Mayer; Joseph E Rubin
Journal:  Can Vet J       Date:  2012-11       Impact factor: 1.008

2.  Multilocus sequence typing for characterization of Staphylococcus pseudintermedius.

Authors:  S M Solyman; C C Black; B Duim; V Perreten; E van Duijkeren; J A Wagenaar; L C Eberlein; L N Sadeghi; R Videla; D A Bemis; S A Kania
Journal:  J Clin Microbiol       Date:  2012-10-31       Impact factor: 5.948

3.  Antimicrobials from a feline commensal bacterium inhibit skin infection by drug-resistant S. pseudintermedius.

Authors:  Alan M O'Neill; Kate A Worthing; Nikhil Kulkarni; Fengwu Li; Teruaki Nakatsuji; Dominic McGrosso; Robert H Mills; Gayathri Kalla; Joyce Y Cheng; Jacqueline M Norris; Kit Pogliano; Joe Pogliano; David J Gonzalez; Richard L Gallo
Journal:  Elife       Date:  2021-10-19       Impact factor: 8.140

4.  Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): antimicrobial-resistant Staphylococcus pseudintermedius in dogs and cats.

Authors:  Søren Saxmose Nielsen; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Barbara Padalino; Paolo Pasquali; Helen Clare Roberts; Hans Spoolder; Karl Ståhl; Antonio Velarde; Arvo Viltrop; Christoph Winckler; Francesca Baldinelli; Alessandro Broglia; Lisa Kohnle; Julio Alvarez
Journal:  EFSA J       Date:  2022-02-01

5.  Staphylococcus pseudintermedius Surface Protein L (SpsL) Is Required for Abscess Formation in a Murine Model of Cutaneous Infection.

Authors:  Amy C Richards; Marie O'Shea; Philippa M Beard; Mariya I Goncheva; Stephen W Tuffs; J Ross Fitzgerald; Andreas Lengeling
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

6.  Understanding the Virulence of Staphylococcus pseudintermedius: A Major Role of Pore-Forming Toxins.

Authors:  Yousef Maali; Cédric Badiou; Patrícia Martins-Simões; Elisabeth Hodille; Michele Bes; François Vandenesch; Gérard Lina; Alan Diot; Frederic Laurent; Sophie Trouillet-Assant
Journal:  Front Cell Infect Microbiol       Date:  2018-06-28       Impact factor: 5.293
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.